Skip to main content

Table 3 Efficacy and Safety

From: Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections

Efficacy and Safety

Ertapenem

N = 167

Aminoglycoside

N = 17

P-value

Efficacy

 Return to hospital or clinic within 90 days for UTI, n (%)

46 (28)

3 (18)

0.57

Safety

 Any Adverse effect

5 (3)

Nausea/vomiting, bilateral extremity heaviness, facial swelling, cramping, hallucination, rash/petechiae and intestinal cramping and loss of appetite

0 (0)

No incidence of ototoxicity or nephrotoxicity

0.99